Loading...

Natural Health Trends Corp.

NHTCNASDAQ
Consumer Cyclical
Specialty Retail
$4.36
$0.00(0.00%)

Natural Health Trends Corp. (NHTC) Financial Performance & Income Statement Overview

Access detailed quarterly and annual financial reports for Natural Health Trends Corp. (NHTC), covering cash flow, earnings, and balance sheets.

Revenue Growth
-2.19%
2.19%
Operating Income Growth
22.26%
22.26%
Net Income Growth
0.70%
0.70%
Operating Cash Flow Growth
21.29%
21.29%
Operating Margin
-3.26%
3.26%
Gross Margin
73.97%
73.97%
Net Profit Margin
0.83%
0.83%
ROE
1.09%
1.09%
ROIC
-4.55%
4.55%

Natural Health Trends Corp. (NHTC) Income Statement & Financial Overview

View the income breakdown for Natural Health Trends Corp. NHTC across both annual and quarterly reports.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$10.74M$10.85M$10.69M$10.47M
Cost of Revenue$2.83M$2.80M$2.77M$2.73M
Gross Profit$7.91M$8.04M$7.93M$7.74M
Gross Profit Ratio$0.74$0.74$0.74$0.74
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$8.25M$8.46M$8.20M$7.98M
Operating Expenses$8.25M$8.46M$8.20M$7.98M
Total Costs & Expenses$11.08M$11.27M$10.97M$10.71M
Interest Income$0.00$0.00$0.00$0.00
Interest Expense$0.00$0.00$0.00$0.00
Depreciation & Amortization$0.00$31000.00$31000.00$34000.00
EBITDA-$315000.00-$421000.00-$244000.00-$204000.00
EBITDA Ratio-$0.03-$0.04-$0.02-$0.02
Operating Income-$345000.00-$421000.00-$275000.00-$238000.00
Operating Income Ratio-$0.03-$0.04-$0.03-$0.02
Other Income/Expenses (Net)$465000.00$396000.00$441000.00$519000.00
Income Before Tax$120000.00-$25000.00$166000.00$281000.00
Income Before Tax Ratio$0.01-$0.002$0.02$0.03
Income Tax Expense-$2000.00-$201000.00$131000.00$108000.00
Net Income$122000.00$176000.00$35000.00$173000.00
Net Income Ratio$0.01$0.02$0.003$0.02
EPS$0.01$0.02$0.003$0.02
Diluted EPS$0.01$0.02$0.003$0.02
Weighted Avg Shares Outstanding$11.49M$11.47M$11.47M$11.46M
Weighted Avg Shares Outstanding (Diluted)$11.49M$11.49M$11.49M$11.48M

Over the past four quarters, Natural Health Trends Corp. demonstrated steady revenue growth, increasing from $10.47M in Q2 2024 to $10.74M in Q1 2025. Operating income reached -$345000.00 in Q1 2025, maintaining a consistent -3% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$315000.00, reflecting operational efficiency. Net income dropped to $122000.00, with EPS at $0.01. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;